लोड हो रहा है...
Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn’s Disease
BACKGROUND AND AIMS: The current approach to managing the loss of response to anti-tumour necrosis factor (TNF) agents is generally empirical. Prior studies have suggested that adalimumab levels of >4.9 µg/mL are required to achieve clinical remission. Our aim was to identify an optimal adalimuma...
में बचाया:
| में प्रकाशित: | J Crohns Colitis |
|---|---|
| मुख्य लेखकों: | , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Oxford University Press
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4957459/ https://ncbi.nlm.nih.gov/pubmed/26783345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjw014 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|